Melbourne, Victoria, Australia.
+61 3 8559 6530
Subscribe
Email Us
Home
About Us
Research
Governance Committee
Resources
Publications
MRV Newsletters
MRV Consumers
Clare Oliver
Donate
About Melanoma
All Melanoma News
For Patients
About Melanoma
MRV Consumers
AMCA – Australian Melanoma Cancer Alliance
MRV Newsletters
Events
For Researchers
Collaborate Now
Resources
MRV Cohort
Clinical Data
MRV Biospecimens
Quality of Life Data
Follow Up Data
MRV Research Projects
Working with Consumers
Melanoma News
Events
Contact Us
Collaborate Now
resected melanoma
Nivolumab More Effective Than Ipilimumab in Resected High-Risk Melanoma
Menu
